| Literature DB >> 25028665 |
Martina Barchitta1, Annalisa Quattrocchi1, Veronica Adornetto1, Anna Elisa Marchese2, Antonella Agodi1.
Abstract
The present study was conducted in order to (i) characterize the adherence to the Mediterranean diet (MD) pattern and fatty acids (FAs) intakes and (ii) explore interactions between TNFA -308 G>A polymorphism and adherence to MD and FAs intakes, respectively, on overweight/obesity risk. From 2010 to 2013, 380 healthy women were enrolled, and MD score (MDS) and FAs intakes were evaluated by a Food Frequencies Questionnaire in relation to nutritional status. TNFA -308 G/A polymorphism was characterized using PCR-RFLP. A total of 32.6% of women were overweight or obese. Lower mean MDS values were more observed in the younger age group than in the older age group (3.60 versus 4.45). The risk of being overweight/obese was 3.5-fold increased due to poor adherence to MD and was about twofold increased in less educated women. Furthermore, younger age was associated with poor adherence to MD. No evidence for an independent effect of the polymorphism on overweight/obesity risk was found. There was no evidence of biological interaction from the gene-diet interaction analyses. Young women, less educated and with poor adherence to MD, are a target group for the nutritional interventions that aimed to control the obesity risk, thus improving the adherence to MD and particularly the intake of unsaturated FAs.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25028665 PMCID: PMC4083707 DOI: 10.1155/2014/742620
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Characteristics of study participants (N = 380).
|
| |
|---|---|
| Education (years of schooling) | |
| ≤8 (low) | 202 (53.3) |
| ≤13 (medium) | 126 (33.2) |
| >13 (high) | 51 (13.5) |
| Employment status | |
| Employed | 120 (31.9) |
| Unemployed | 33 (8.8) |
| Student | 46 (12.2) |
| Housewife | 177 (47.1) |
| BMI | |
| Underweight | 33 (8.7) |
| Normal weight | 223 (58.7) |
| Overweight | 78 (20.5) |
| Obese | 46 (12.1) |
| Smoking | |
| Current smokers | 90 (23.7) |
| Nonsmokers | 244 (64.4) |
| Former smokers | 45 (11.9) |
| Pregnancy status (yes) | 203 (53.4) |
| MDS | |
| 0–3 (≤25th percentile) | 140 (36.8) |
| 4–6 (>25th percentile–≤90th percentile) | 209 (55.0) |
| 7–9 (>90th percentile) | 31 (8.2) |
|
| |
| GG | 306 (80.5) |
| GA | 69 (18.2) |
| AA | 5 (1.3) |
BMI: body mass index; MDS: Mediterranean diet score.
Fatty acids and energy intakes in underweight/normal weight and overweight/obese womena.
| Nutrient intake (g/day) | Underweight/normal weight | Overweight/obese |
|
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Linoleic acid | 17.07 ± 12.09 | 12.66 ± 8.05 |
|
| Arachidonic acid | 0.18 ± 0.28 | 0.13 ± 0.06 |
|
|
| 1.60 ± 1.10 | 1.20 ± 0.54 |
|
|
| 1.60 ± 1.11 | 1.21 ± 0.53 |
|
| Eicosapentaenoic acid | 0.13 ± 0.23 | 0.08 ± 0.07 |
|
| Docosahexaenoic acid | 0.30 ± 0.67 | 0.20 ± 0.14 |
|
| Polyunsaturated fatty acids | 18.43 ± 10.10 | 14.50 ± 9.10 |
|
| Monounsaturated fatty acids | 55.25 ± 25.24 | 47.41 ± 23.88 |
|
| Total unsaturated fatty acids | 73.68 ± 33.27 | 61.91 ± 31.62 |
|
| Unsaturated/saturated fatty acids ratio | 2.34 ± 0.69 | 2.34 ± 0.66 | 0.990 |
| Saturated fatty acids | 33.65 ± 18.13 | 27.33 ± 13.65 |
|
| Palmitic acid | 19.35 ± 13.18 | 15.01 ± 7.12 |
|
| Energy intake (Kcal/day) | 2272.0 | 1811.1 |
|
aStatistically significant P values (P < 0.05) are indicated in bold font.
bStudent's t-test for the comparison of means between underweight/normal weight women and overweight/obese women (two-sided P values).
Fatty acids and energy intakes between women with greater adherence to MD and women with lower adherence to MDa.
| Nutrient intake (g/day) | MDS ≤ 6 | MDS > 6 |
|
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Linoleic acid | 15.24 ± 10.94 | 20.05 ± 12.39 |
|
| Arachidonic acid | 0.16 ± 0.24 | 0.17 ± 0.08 | 0.830 |
|
| 1.44 ± 0.98 | 1.80 ± 0.75 |
|
|
| 1.44 ± 0.99 | 1.80 ± 0.67 |
|
| Eicosapentaenoic acid | 0.11 ± 0.20 | 0.16 ± 0.10 |
|
| Docosahexaenoic acid | 0.26 ± 0.58 | 0.34 ± 0.16 | 0.081 |
| Polyunsaturated fatty acids | 16.69 ± 9.53 | 22.35 ± 12.85 |
|
| Monounsaturated fatty acids | 51.36 ± 24.27 | 67.64 ± 28.95 |
|
| Total unsaturated fatty acids | 68.05 ± 31.95 | 89.99 ± 39.90 |
|
| Unsaturated/saturated fatty acids ratio | 2.32 ± 0.68 | 2.67 ± 0.62 |
|
| Saturated fatty acids | 31.26 ± 16.93 | 35.26 ± 18.18 | 0.210 |
| Palmitic acid | 17.74 ± 11.88 | 20.16 ± 9.65 | 0.197 |
| Energy intake (Kcal/day) | 2065.7 ± 897.5 | 2750 ± 1006.7 |
|
aStatistically significant P values (P < 0.05) are indicated in bold font.
bStudent's t-test for the comparison of means between MDS ≤ 6 and MDS > 6 (two-sided P values).
TNFA −308 G>A polymorphism and unsaturated fatty acids intake interactions on overweight/obesity riska,b.
| Fatty acids | Ac
| Bd
| A + Be
| Synergy index |
|---|---|---|---|---|
| Linoleic acid | 2.68 (0.83–8.66) | 3.61 (1.85–7.45) | 4.27 (1.78–10.26) | 0.76 (0.28–2.07) |
| Arachidonic acid | 4.41 (1.53–12.72) | 2.41 (1.25–4.64) | 2.18 (0.94–5.05) | 0.25 (0.06–1.00) |
|
| 3.06 (0.93–10.08) | 3.47 (1.72–6.97) | 3.80 (1.63–8.84) | 0.62 (0.22–1.76) |
|
| 3.98 (1.24–12.78) | 4.20 (2.00–8.82) | 4.40 (1.81–10.70) | 0.55 (0.21–1.46) |
| Eicosapentaenoic acid | 4.44 (1.43–13.73) | 2.66 (1.35–5.23) | 2.56 (1.10–5.94) | 0.31 (0.09–1.10) |
| Docosahexaenoic acid | 2.50 (0.85–7.32) | 2.34 (1.21–4.54) | 2.75 (1.19–6.34) | 0.62 (0.18–2.12) |
| Polyunsaturated fatty acids | 2.94 (0.90–9.56) | 3.31 (1.64–6.68) | 3.68 (1.57–8.63) | 0.63 (0.22–1.84) |
| Monounsaturated fatty acids | 2.58 (0.84–7.92) | 2.18 (1.14–4.17) | 2.48 (1.10–5.57) | 0.54 (0.14–2.02) |
| Total unsaturated fatty acids | 2.36 (0.77–7.20) | 1.96 (1.03–3.72) | 2.27 (1.02–5.07) | 0.55 (0.13–2.29) |
| Unsaturated/saturated fatty acids ratio | 0.86 (0.29–2.58) | 0.71 (0.40–1.26) | 1.13 (0.53–2.41) | — |
aOR adjusted for age, adherence to MD, and education.
bReference category: individuals carrying the homozygous wild-type genotype GG who had not been exposed to environmental factor.
cA: risk of developing overweight/obesity in carriers of TNFA −308 A allele (individuals carrying the homozygous mutated genotype or the heterozygous genotype AA or AG, who had not been exposed to environmental factor-FAs intakes above the 75th percentile of the unsaturated FAs intakes distribution).
dB: risk of developing overweight/obesity in women exposed to environmental factor only (individuals carrying the homozygous wild-type genotype GG, who had been exposed to environmental factor-FAs intakes below or equal to the 75th percentile of the unsaturated FAs intakes distribution).
eA + B: risk of developing overweight/obesity in women exposed to both A and B (individuals carrying the homozygous mutated genotype or the heterozygous genotype AA or AG, who had been exposed to environmental factor-FAs intakes below or equal to the 75th percentile of the unsaturated FAs intakes distribution).
TNFA −308 G>A polymorphism and saturated fatty acids intake interactions on overweight/obesity riska,b.
| Fatty acids | Ac
| Bd
| A + Be
| Synergy index |
|---|---|---|---|---|
| Palmitic acid | 0.94 (0.50–1.76) | 0.26 (0.13–0.53) | 1.34 (0.49–3.71) | — |
| Saturated fatty acids | 1.11 (0.59–2.10) | 0.29 (0.15–0.59) | 0.90 (0.33–2.43) | — |
aOR adjusted for age, adherence to MD, and education.
bReference category: individuals carrying the homozygous wild-type genotype GG, who had not been exposed to environmental factor.
cA: risk of developing overweight/obesity in carriers of TNFA −308 A allele (individuals carrying the homozygous mutated genotype or the heterozygous genotype AA or AG, who had not been exposed to environmental factor-FAs intakes below the 75th percentile of the saturated FAs intakes distribution).
dB: risk of developing overweight/obesity in women exposed to environmental factor only (individuals carrying the homozygous wild-type genotype GG, who had been exposed to environmental factor-FAs intakes above the 75th percentile of the saturated FAs intakes distribution).
eA + B: risk of developing overweight/obesity in women exposed to both A and B (individuals carrying the homozygous mutated genotype or the heterozygous genotype AA or AG, who had been exposed to environmental factor-FAs intakes above the 75th percentile of the saturated FAs intakes distribution).